SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

Prelude Therapeutics Q4 EPS $(0.45)

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.45) per share.

· 03/16/2021 08:25
Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.45) per share.